Results 11 to 20 of about 14,247 (191)
The Journal of Infectious Diseases, 2021 Abstract Herpes zoster (HZ) affects approximately 1 in 3 persons in their lifetime, and the risk of HZ increases with increasing age. The most common, debilitating complication of HZ is the chronic neuropathic pain of postherpetic neuralgia (PHN).
Harbecke, Ruth +2 more
openaire +2 more sources
Herpes zoster after COVID vaccination [PDF]
International Journal of Infectious Diseases, 2021 COVID-19 presents in various ways, but mainly as a pulmonary disease (Marzano, 2020). Skin manifestations have been reported, including reactivation of the varicella-zoster virus (Marzano, 2020). Our case report describes two adults developing herpes zoster after vaccination with tozinameran (the Pfizer-BioNTech COVID-19 mRNA vaccine). A possible cause
C.S. van Dam +5 more
openaire +4 more sources
Reactivation of Herpes Zoster Keratitis Following Shingrix Vaccine
Case Reports in Ophthalmology, 2022 We present a case of herpes zoster keratitis reactivation shortly following the Shingrix vaccine. In our patient, reactivation of herpes zoster keratitis occurred a few weeks following the herpes zoster subunit (HZ/su) vaccine.
Tracy J. Lu, Christopher N. Ta
doaj +1 more source
Research Trends and Hotspots on Herpes Zoster: A 10-Year Bibliometric Analysis (2012–2021)
Frontiers in Medicine, 2022 PurposeHerpes zoster infection, with its considerable burden to individuals and society, remains a challenge around the world. However, to the knowledge of the authors, little bibliometric quantitative or qualitative analysis has been carried out to ...
Jian Zhang +6 more
doaj +1 more source
Pharmaceutics, 2022 Varicella zoster virus (VZV) causes two diseases: varicella upon primary infection and herpes zoster when latent viruses in the sensory ganglia reactivate.
Ning Luan +4 more
doaj +1 more source
Post COVID-19 Immunization Herpes Zoster Reactivation In Asia : A Literature Review
Jurnal Kedokteran Diponegoro, 2023 Background: The COVID-19 vaccine that targets viral mRNA has been created and can be used as an effort to end the COVID-19 pandemic that has hit the world since 2020.
Nurul Nisa Ulfa +2 more
doaj +1 more source
The Journal of Infectious Diseases, 2018 Immunization for herpes zoster (HZ) aims to reverse the decline in cell-mediated immunity to varicella zoster virus that occurs with advancing age or immunocompromise. There are 2 vaccines available, one live attenuated (Zoster vaccine, live attenuated [ZVL]) and, recently, a recombinant subunit vaccine (HZ/su).The literature relevant to the two HZ ...
Anthony L, Cunningham, Myron J, Levin
openaire +2 more sources
Avoiding rash decisions about zoster vaccination: insights from cost-effectiveness evidence
BMC Medicine, 2018 de Boer and colleagues present a cost-effectiveness analysis based in the Netherlands of two vaccines available for the prevention of herpes zoster. Zostavax® was the first vaccine available for the prevention of herpes zoster in older adults.
Chester B. Good +2 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2020 Herpes zoster (shingles) is a painful condition resulting from reactivation of latent varicella zoster virus (VZV). The Australian National Shingles Vaccination Program (commenced November 2016) provides free herpes zoster vaccination for eligible adults
John Litt +8 more
doaj +1 more source
Herpes zoster and subunit vaccine
Uirusu, 2021 Varicella-zoster virus (VZV) causes varicella (chickenpox) as primary infection, and latently infects neuronal cells in the dorsal root ganglia (DRG). Reactivation of VZV from DRG results in herpes zoster, often decades later. VZV is the only airborne human herpesvirus and the only herpesvirus whose symptoms (both varicella and herpes zoster) can be ...
openaire +2 more sources